Reloxin Approval Status beta

  • FDA approved: No
  • Brand name: Reloxin
  • Generic name: botulinum toxin type A
  • Company: Ipsen and Medicis
  • Treatment for: Aesthetics

Reloxin (botulinum toxin type A) is a neurotoxin in development for the temporary improvement in the appearance of some facial wrinkles.

FDA Approval Status for Reloxin

DateArticle
May 19, 2008Ipsen and Medicis Announce Acceptance of Reloxin BLA in Aesthetics by FDA
Mar 17, 2008Ipsen and Medicis announce submission of Reloxin BLA in aesthetics to the FDA
Dec  6, 2007Ipsen and Medicis Announce Submission of Reloxin in Aesthetics to the FDA

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web3)